Cargando…
Clinical potential of ataluren in the treatment of Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) is an autosomal dominant, X-linked neuromuscular disorder caused by mutations in dystrophin, one of the largest genes known to date. Dystrophin gene mutations are generally transmitted from the mother to male offspring and can occur throughout the coding length of t...
Autores principales: | Namgoong, John Hyun, Bertoni, Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053089/ https://www.ncbi.nlm.nih.gov/pubmed/30050367 http://dx.doi.org/10.2147/DNND.S71808 |
Ejemplares similares
-
Treatment with Ataluren for Duchene Muscular
Dystrophy
por: Morkous, Sameh S.
Publicado: (2020) -
Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients
por: McDonald, Craig M, et al.
Publicado: (2021) -
Phase 2a Study of Ataluren-Mediated Dystrophin Production in Patients with Nonsense Mutation Duchenne Muscular Dystrophy
por: Finkel, Richard S., et al.
Publicado: (2013) -
One-year follow up of three Italian patients with Duchenne muscular
dystrophy treated with ataluren: is earlier better?
por: Ruggiero, Lucia, et al.
Publicado: (2018) -
Early treatment with Ataluren of a 2-year-old boy with nonsense mutation Duchenne dystrophy
por: Bitetti, Ilaria, et al.
Publicado: (2021)